Muscle unloading-induced metabolic remodeling is associated with acute alterations in PPARδ and UCP-3 expression

Physiological Genomics

Volumn 34, Issue 2, 2008, Pages 149-161

  Mazzatti, Dawn J ^a   Smith, Melissa A ^b   Oita, Radu C ^a   Lim, Fei Ling ^a   White, Andrew J ^a   Reid, Michael B ^b  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Fuel utilization; Gene expression; Hindlimb suspension; Metabolic flexibility; Microarray; Peroxisome proliferator activated receptor; Uncoupling protein 3

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCOUPLING PROTEIN 3; GLUCOSE; ION CHANNEL; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; EARLY RESPONSE GENE; GASTROCNEMIUS MUSCLE; GLUCOSE METABOLISM; IMMOBILIZATION; LIPID METABOLISM; MALE; MOUSE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; UPREGULATION; ANIMAL; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; SKELETAL MUSCLE; TIME;

ANIMALS; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GLUCOSE; HINDLIMB SUSPENSION; ION CHANNELS; LIPID METABOLISM; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; PPAR DELTA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 49049114550     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00281.2007     Document Type: Article

References (84)

1. Acheson KJ, Decombaz J, Piguet-Welsch C, Montigon F, Decarli B, Bartholdi I, Fern EB. Energy, protein, and substrate metabolism in simulated microgravity. Am J Physiol Regul Integr Comp Physiol 269: R252-R260, 1995.
2. Arbogast S, Smith J, Matuszczak Y, Hardin BJ, Moylan JS, Smith JD, Ware J, Kennedy AR, Reid MB. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J Appl Physiol 102: 956-964, 2007.
3. Baldwin KM, Herrick RE, McCue SA. Substrate oxidation capacity in rodent skeletal muscle: effects of exposure to zero gravity. J Appl Physiol 75: 2466-2470, 1993.
4. Bey L, Akunuri N, Zhao P, Hoffman EP, Hamilton DG, Hamilton MT. Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity. Physiol Genomics 13: 157-167, 2003.
5. Beyer RE, Fattore JE. The influence of age and endurance exercise on the myoglobin concentration of skeletal muscle of the rat. J Gerontol 39: 525-530, 1984.
6. Bing C, Brown M, King P, Collins P, Tisdale MJ, Williams G. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. Cancer Res 60: 2405-2410, 2000.
7. Bonadonna RC, Groop LC, Simonson DC, DeFronzo RA. Free fatty acid and glucose metabolism in human aging: evidence for the operation of the Randle cycle. Am J Physiol Endocrinol Metab 266: E501-E509, 1994.
8. Boss O, Samec S, Dulloo A, Seydoux J, Muzzin P, Giacobino JP. Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett 412: 111-114, 1997.
9. Boss O, Bobbioni-Harsch E, Assimacopoulos-Jeannet F, Muzzin P, Munger R, Giacobino JP, Golay A. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. Lancet 351: 1933, 1998.
10. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 6: 1887-1889, 1997.
11. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
12. Brunmair B, Gras F, Wagner L, Artwohl M, Zierhut B, Waldhausl W, Furnsinn C. Expression of uncoupling protein-3 mRNA in rat skeletal muscle is acutely stimulated by thiazolidinediones: an exercise-like effect? Diabetologia 47: 1611-1614, 2004.
13. Busquets S, Carbo N, Almendro V, Figueras M, Lopez-Soriano FJ, Argiles JM. Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia? FEBS Lett 505: 255-258, 2001.
14. Campbell DA, Sundaramurthy D, Gordon D, Markham AF, Pieri LF. Association between a marker in the UCP-2/UCP3 gene cluster and genetic susceptibility to anorexia nervosa. Mol Psychiatry 4: 68-70, 1999.
15. Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, Carter SA, Lehner I, Smith SA, Beeley LJ, Godden RJ, Herrity N, Skehel M, Changani KK, Hockings PD, Reid DG, Squires SM, Hatcher J, Trail B, Latcham J, Rastan S, Harper AJ, Cadenas S, Buckingham JA, Brand MD, Abuin A. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406: 415-418, 2000.
16. Collins P, Bing C, McCulloch P, Williams G. Muscle UCP3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans. Br J Cancer 86: 372-375, 2002.
17. Constantin D, Constantin-Teodosiu D, Layfield R, Tsintzas K, Bennett AJ, Greenhaff PL. PPARδ agonism induces a change in muscle fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle. J Physiol 583: 381-390, 2007.
18. Cros N, Tkatchenko AV, Pisani DF, Leclerc L, Leger JJ, Marini JF, Dechesne CA. Analysis of altered gene expression in rat soleus muscle atrophied by disuse. J Cell Biochem 83: 508-519, 2001.
19. de Lange P, Feola A, Ragni M, Senese R, Moreno M, Lombardi A, Silvestri E, Amat R, Villarroya F, Goglia F, Lanni A. Differential 3,5,3′-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of fatty acids. Endocrinology 148: 4064-4072, 2007.
20. Denjean F, Desplanches D, Lachuer J, Cohen-Adad F, Mayet MH, Duchamp C. Muscle-specific up-regulation of rat UCP3 mRNA expression by long-term hindlimb unloading. Biochem Biophys Res Commun 266: 518-522, 1999.
21. Doenst T, Goodwin GW, Cedars AM, Wang M, Stepkowski S, Taegtmeyer H. Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism 50: 1083-1090, 2001.
22. Dokladda K, Green KA, Pan DA, Hardie DG. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP: ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett 579: 236-240, 2005.
23. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477-2493, 2003.
24. Farid M, Reid MB, Li YP, Gerken E, Durham WJ. Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus. Nutr Metab (Lond) 2: 20, 2005.
25. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272, 1997.
26. Fritz T, Kramer DK, Karlsson HK, Galuska D, Engfeldt P, Zierath JR, Krook A. Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev 22: 492-498, 2006.
27. Fürnsinn C, Willson TM, Brunmair B. Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia 50: 8-17, 2007.
28. Goglia F, Skulachev VP. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J 17: 1585-1591, 2003.
29. Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res 10: 575-584, 2002.
30. Grichko VP, Heywood-Cooksey A, Kidd KR, Fitts RH. Substrate profile in rat soleus muscle fibers after hindlimb unloading and fatigue. J Appl Physiol 88: 473-478, 2000.
31. Hamilton MT, Booth FW. Skeletal muscle adaptation to exercise: a century of progress. J Appl Physiol 88: 327-331, 2000.
32. Henriksen EJ, Tischler ME. Glucose uptake in rat soleus: effect of acute unloading and subsequent reloading. J Appl Physiol 64: 1428-1432, 1988.
33. Himms-Hagen J, Harper ME. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: a hypothesis. Exp Biol Med (Maywood) 226: 78-84, 2001.
34. Huey KA, Roy RR, Baldwin KM, Edgerton VR. Temporal effects of inactivity on myosin heavy chain gene expression in rat slow muscle. Muscle Nerve 24: 517-526, 2001.
35. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 95: 568-578, 2004.
36. Jucker BM, Doe CP, Schnackenberg CG, Olzinski AR, Maniscalco K, Williams C, Hu TC, Lenhard SC, Costell M, Bernard R, Sarov-Blat L, Steplewski K, Willette RN. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure. J Cardiovasc Pharmacol 50: 25-34, 2007.
37. Kang J, Kelley DE, Robertson RJ, Goss FL, Suminski RR, Utter AC, Dasilva SG. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 31: 82-89, 1999.
38. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-683, 2000.
39. Kodde IF, van der Stok J, Smolenski RT, de Jong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A 146: 26-39, 2007.
40. Konrad D, Rudich A, Bilan PJ, Patel N, Richardson C, Witters LA, Klip A. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 48: 954-966, 2005.
41. Krämer DK, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, Kannisto K, Wallberg-Henriksson H, Ehrenborg E, Zierath JR, Krook A. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 54: 1157-1163, 2005.
42. Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282: 19313-19320, 2007.
43. Langfort J, Zernicka E, Mayet-Sornay MH, Dubaniewicz A, Desplanches D. Effects of acute and chronic hindlimb suspension on sensitivity and responsiveness to insulin in the rat soleus muscle. Biochem Cell Biol 75: 41-44, 1997.
44. Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun 340: 291-295, 2006.
45. Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31: 224-227, 2003.
46. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116: 1776-1783, 2006.
47. Luquet S, Lopez-Soriano J, Holst D, Gaudel C, Jehl-Pietri C, Fredenrich A, Grimaldi PA. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 86: 833-837, 2004.
48. Matuszczak Y, Arbogast S, Reid MB. Allopurinol mitigates muscle contractile dysfunction caused by hindlimb unloading in mice. Aviat Space Environ Med 75: 581-588, 2004.
49. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1alpha and PPARbeta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond) 31: 1302-1310, 2007.
50. Mensink M, Hesselink MK, Borghouts LB, Keizer H, Moonen-Kornips E, Schaart G, Blaak EE, Schrauwen P. Skeletal muscle uncoupling protein-3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis? Diabetes Obes Metab 9: 594-596, 2007.
51. Minnaard R, Schrauwen P, Schaart G, Hesselink MK. UCP3 in muscle wasting, a role in modulating lipotoxicity? FEBS Lett 580: 5172-5176, 2006.
52. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, Kraus WE. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. J Biol Chem 277: 26089-26097, 2002.
53. Negre-Salvayre A, Hirtz C, Carrera G, Cazenave R, Troly M, Salvayre R, Penicaud L, Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11: 809-815, 1997.
54. Ohira Y, Yasui W, Kariya F, Wakatsuki T, Nakamura K, Asakura T, Edgerton VR. Metabolic adaptation of skeletal muscles to gravitational unloading. Acta Astronaut 33: 113-117, 1994.
55. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12: 331-343, 2007.
56. Ravnskjaer K, Boergesen M, Dalgaard LT, Mandrup S. Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J Mol Endocrinol 36: 289-299, 2006.
57. Riquet FB, Rodriguez M, Guigal N, Dromaint S, Naime I, Boutin JA, Galizzi JP. In vivo characterisation of the human UCP3 gene minimal promoter in mice tibialis anterior muscles. Biochem Biophys Res Commun 311: 583-591, 2003.
58. Ritz P, Acheson KJ, Gachon P, Vico L, Bernard JJ, Alexandre C, Beaufrere B. Energy and substrate metabolism during a 42-day bed-rest in a head-down tilt position in humans. Eur J Appl Physiol Occup Physiol 78: 308-314, 1998.
59. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93: 2379-2386, 1994.
60. Samec S, Seydoux J, Dulloo AG. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J 12: 715-724, 1998.
61. Samec S, Seydoux J, Dulloo AG. Skeletal muscle UCP3 and UCP2 gene expression in response to inhibition of free fatty acid flux through mitochondrial beta-oxidation. Pflügers Arch 438: 452-457, 1999.
62. Sanchis D, Busquets S, Alvarez B, Ricquier D, Lopez-Soriano FJ, Argiles JM. Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett 436: 415-418, 1998.
63. Sbraccia P, D'Adamo M, Leonetti F, Buongiorno A, Silecchia G, Basso MS, Tamburrano G, Lauro D, Federici M, Di Daniele N, Lauro R. Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link. Clin Endocrinol (Oxf) 57: 199-207, 2002.
64. Schrauwen P, Saris WH, Hesselink MK. An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 15: 2497-2502, 2001.
65. Skulachev VP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1363: 100-124, 1998.
66. Son C, Hosoda K, Matsuda J, Fujikura J, Yonemitsu S, Iwakura H, Masuzaki H, Ogawa Y, Hayashi T, Itoh H, Nishimura H, Inoue G, Yoshimasa Y, Yamori Y, Nakao K. Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes. Endocrinology 142: 4189-4194, 2001.
67. St-Amand J, Okamura K, Matsumoto K, Shimizu S, Sogawa Y. Characterization of control and immobilized skeletal muscle: an overview from genetic engineering. FASEB J 15: 684-692, 2001.
68. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129, 2005.
69. Stein TP, Schluter MD, Galante AT, Soteropoulos P, Tolias PP, Grindeland RE, Moran MM, Want TJ, Polansky M, Wade CE. Energy metabolism pathways in rat muscle under conditions of simulated microgravity. J Nutr Biochem 13: 471-478, 2002.
70. Stevenson EJ, Giresi PG, Koncarevic A, Kandarian SC. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551: 33-48, 2003.
71. Stoppani J, Hildebrandt AL, Sakamoto K, Cameron-Smith D, Goodyear LJ, Neufer PD. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am J Physiol Endocrinol Metab 283: E1239-E1248, 2002.
72. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann NY Acad Sci 1015: 202-213, 2004.
73. Taegtmeyer H, Wilson CR, Razeghi P, Sharma S. Metabolic energetics and genetics in the heart. Ann NY Acad Sci 1047: 208-218, 2005.
74. Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol 68: 1-12, 1990.
75. Tischler ME, Jaspers SR, Henriksen EJ, Jacob S. Responses of skeletal muscle to unloading - a review. Physiologist 28, Suppl: S13-S16, 1985.
76. Ukkola O, Tremblay A, Sun G, Chagnon YC, Bouchard C. Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. Eur J Clin Nutr 55: 1008-1015, 2001.
77. Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 56: 720-727, 2007.
78. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J, Warden CH, Pecqueur C, Raimbault S, Ricquier D, Silver MH, Shuldiner AR, Solanes G, Lowell BB, Chung WK, Leibel RL, Pratley R, Ravussin E. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 7: 1431-1435, 1998.
79. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113: 159-170, 2003.
80. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2: e294, 2004.
81. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47: 298-302, 1998.
82. Wittwer M, Fluck M, Hoppeler H, Muller S, Desplanches D, Billeter R. Prolonged unloading of rat soleus muscle causes distinct adaptations of the gene profile. FASEB J 16: 884-886, 2002.
83. Yajid F, Mercier JG, Mercier BM, Dubouchaud H, Préfaut C. Effects of 4 wk of hindlimb suspension on skeletal muscle mitochondrial respiration in rats. J Appl Physiol 84: 479-485, 1998.
84. Zimmerman AW, Veerkamp JH. Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J 360: 159-165, 2001.